{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/66746a40c23b2c0012836d55/673687bbd3a0091de28986c4?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"How we can overcome patient access hurdles ","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/66746a40c23b2c0012836d55/1731626900076-b4f944a5-bec1-4fc8-876c-be93d15f54ec.jpeg?height=200","description":"<p>In the final episode of Season 2, we look at the future of healthcare in Central Europe and the Baltics, a diverse region that covers almost one third of EU countries. </p><p>&nbsp;</p><p>Tuba Atahan, Managing Director, and Laura Saar, Market Access Director, for Central Europe and Baltics delve into the current barriers to healthcare access in the region – such as the growing disparity in multiple myeloma care – and discuss innovative solutions that will help close the gap.</p><p>&nbsp;</p><p><em>This recording was organised and funded by Johnson &amp; Johnson </em></p><p><em>November 2024</em></p><p><em>CP-485355 | CP-485428</em></p>","author_name":"Johnson & Johnson"}